Medicare Program Already Denying Care in 6 States, Report Finds
A six-state AI pilot for Original Medicare is delaying and denying care for certain procedures, drawing bipartisan sc...
Innovative Skincare Clinical presents study results and product evaluations to help you assess effectiveness and safety in modern skincare.
1,173 articlesA six-state AI pilot for Original Medicare is delaying and denying care for certain procedures, drawing bipartisan sc...
Asia’s aging demographics are fueling a surge in high-end longevity clinics and wellness residencies, creating new op...
As Seer gears up for 2025 earnings, investors weigh growth, margins, and risk. This guide breaks down the drivers beh...
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Investors are watching Eli Lilly as GLP-1 drugs like Mounjaro and Zepbound power growth. This article breaks down the...
Investors eyeing SPRY's Q1 2026 results should understand how to parse a pharma earnings transcript. This guide break...
Crispr Therapeutics Stock Absurdly Cheap signals a rare biotech bargain. Learn what could drive a 437% upside, the ca...
Want to know if Bristol Myers Squibb is worth a spot in your portfolio? This deep dive highlights three core reasons ...
A new era of obesity and diabetes treatment access could lift Lilly stock. This article breaks down how an oral GLP-1...
Biodesix faces a pivotal year in 2025. This guide breaks down the factors shaping biodesix (bdsx) 2025 earnings, the ...
The weight loss drug space has become a focus for growth-minded investors. This guide weighs Eli Lilly's proven progr...
A limited hantavirus outbreak has sent waves through biotech stocks, mirroring post-pandemic behavior. This article b...